This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
https://www.barrons.com/articles/moderna-stock-jumps-as-analyst-expects-the-fda-to-approve-its-covid-19-vaccine-51594653061
-
Order Reprints
-
Print Article
Shares of Moderna are up 239% so far this year, and the biotech company, which has no approved drugs, has a market capitalization of more than $24 billion.
But in a note out Monday morning, Jefferies analyst Michael Yee writes that the stock can still climb higher.
The…